A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy. Now, the company has made a move to try to make sure it isn't ...
A modern, simple TCP tunnel in Rust that exposes local ports to a remote server, bypassing standard NAT connection firewalls. That's all it does: no more, and no less. (bore totals about 400 lines of ...